Results 161 to 170 of about 34,871 (236)

How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience. [PDF]

Pharmaceuticals (Basel)
Di Iorio V, Boschi S, Brugugnoli E, Sansovini M, Matteucci F, Masini C, Monti M.   +6 more
europepmc   +1 more source

Influence of Peptide-Based Chelator Sequences on HER2-Targeting Radiopeptide. [PDF]

J Pept Sci
Gupta S, Kumar M, Repaka KM, Das A, Kengar AA, Satpati D.   +5 more
europepmc   +1 more source

Development of a Highly Effective Bifunctional Ligand 2E-C-NETA for Targeted Lu-177 Therapy: Synthesis, Radiolabeling, In Vitro Stability, and In Vivo Biodistribution. [PDF]

ChemMedChem
Chen Y, Lee Y, Kang CS, Ren S, Chen Y, Wang H, Bandara N, Rogers BE, Chong HS.   +8 more
europepmc   +1 more source

Radionuclide theranostics: advances and clinical applications in lung cancer. [PDF]

Front Oncol
Yang Y, Fu J, Tang S, Liu T, Hu H, Guo H, Wen L, Yang Y, Liu C, Zhang Y, Yu L, Zhou H.   +11 more
europepmc   +1 more source

Synthesis, Radiochemical Characterization, and Biodistribution of a ¹⁸⁸Re Analogue of [¹³¹I]mIBG in a Neuroblastoma Xenograft Model. [PDF]

J Labelled Comp Radiopharm
Sakhare N, Kumar D, Das S, Mitra A, Mirapurkar S, Rani G, Sheela M, Chirayil V, Mohanty B, Mathur A, Mallia MB, Chaudhari P.   +11 more
europepmc   +1 more source

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Zhang S, Liu C, Lu Q, Liu W, Wu J, Liu J, Tong L, Zhao K, Hu Q, Chen X, Li L, Song X, Wang F, Dai D, Wang R, Hu K.   +15 more
europepmc   +1 more source

PET Radiopharmaceuticals.

Iranian journal of pharmaceutical research : IJPR, 2011
openaire   +2 more sources

Picolinamide-functionalized macrocyclic chelators for ^203/212Pb theranostic radiotracers.

Inorg Chem Front
Osborne BE, Siakalli C, Brown RK, White AJP, Rocco C, Weiss D, Delgado-Pinar E, García-España E, Sosabowski JK, Ma MT, Long NJ.   +10 more
europepmc   +1 more source

An intra-patient contemporaneous comparison of ¹⁸F-piflufolastat and ¹⁸F-flotufolastat urinary radioactivity and pelvic region detection rates in men with low PSA biochemical recurrence of prostate cancer after radical prostatectomy. [PDF]

Eur J Nucl Med Mol Imaging
Nordquist LT, Andrews JR, Kuo PH, Gartrell BA, Josephson D, Purysko AS, Saltzstein DR, Pathak RA, Shore N, Sykes J, Penny R, Davis P, Helfand BT.   +12 more
europepmc   +1 more source

Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges. [PDF]

Cancers (Basel)
Maes J, Pôlet B, Kleynhans J, Van Herpe F, Goffin K, Dekervel J, Nafteux P, Topal B, Cleeren F, Deroose CM.   +9 more
europepmc   +1 more source